According to DataM Intelligence, the Insulin Delivery Devices Market Size reached USD 20.26 billion in 2024 and is projected to reach USD 43.11 billion by 2033, growing at a strong CAGR of 8.8% from ...

Corp., a large manufacturer of insulin injection devices, has expanded its partnership with Direct Relief, a leading humanitarian aid organization and large charitable insulin provider in the ...

Q4 2025 Earnings Call November 25, 2025 8:00 AM ESTCompany ParticipantsPravesh Khandelwal - VP & Head of Investor ...

Embecta (Nasdaq:EMBC) today posted fourth-quarter financial results that proved mixed compared to the consensus forecast on ...

Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.

In mice with type 1 diabetes, a topical dose of OP-I was smeared onto the skin. Blood glucose levels fell to a normal range ...

Jacob will then review the financial results for the fourth quarter and full year 2025 and share our preliminary thoughts for ...

Despite its small base, rapid growth in smart insulin administration, connected devices, patient-centric care, and home-based ...

The rising price of insulin has become one of the most talked about issues across the pharma industry. Ben Hargreaves explains how Eli Lilly decided to cap its insulin price, why it has decided to ...

A material that slips through skin might someday make needle-free insulin possible for people with diabetes. In mice and mini pigs, attaching the permeating polymer to insulin and applying the ...

The Company’s Board of Directors declared a quarterly cash dividend of $0.15 for each issued and outstanding share of the Company’s common stock. The dividend is payable on December 18, 2025 to ...